Back to News
Market Impact: 0.28

NuScale Power Is on Sale. Could This Be the Buy That Sets You Up for Life?

Artificial IntelligenceEnergy Markets & PricesTechnology & InnovationRegulation & LegislationCompany FundamentalsCorporate EarningsInvestor Sentiment & PositioningRenewable Energy Transition
NuScale Power Is on Sale. Could This Be the Buy That Sets You Up for Life?

NuScale Power remains the only U.S. SMR developer with NRC approval, but it is still unprofitable, posting about a $44 million net loss in Q1 and has yet to secure a commercial deployment. The stock is down over 75% from its recent all-time high, reflecting investor skepticism despite potential demand from AI-driven data centers and clean energy needs. The article highlights long-term upside if NuScale can scale, but near-term sentiment is cautious due to cost overruns, delayed commercialization, and emerging competition.

Analysis

The key market misread is that this is not a pure “nuclear adoption” story; it is a procurement-cycle and financing story. The first commercial winners in SMRs are likely to be the firms that can underwrite execution risk and standardize deployments, not necessarily the first design to get regulatory approval. That means the near-term equity upside is gated by contract conversion and bankable project finance, while the biggest competitive threat is not another headline-grabbing developer but utility-scale gas, behind-the-meter generation, and grid upgrades that can be delivered faster and with fewer political constraints.

The second-order effect is that the data-center power shortage can accelerate demand for any firm that offers firm, carbon-lite baseload, but it also raises the bar on reliability and delivery certainty. If SMRs miss on schedule by even 12-18 months, hyperscalers will likely lock in multi-year alternatives, which would push the monetization window further out and compress multiple expansion across the entire SMR basket. In that sense, the negative read-through is broader for the category than for SMR alone: OKLO remains the higher-beta expression of the same adoption risk and should trade with a larger duration discount.

The contrarian take is that the stock may already be discounting failure too aggressively, but not enough for a business model that is still pre-revenue at scale and dependent on one-off project wins. If even one of the current pathways reaches FID, the market could re-rate the name sharply on option value; if not, the equity is likely to remain a sentiment vehicle rather than a fundamentals vehicle for several quarters. The catalyst stack is binary and slow-moving: regulatory progress is supportive, but the real inflection is signed financing plus a credible construction schedule, likely a 6-18 month window rather than a days-to-weeks trade.